Stakeholders Oppose Proposal To Cut IVIG Preadministration Fee In Medicare
Executive Summary
Industry groups are asking CMS to back off on a proposal to cut the $37 preadministration fee for intravenous immune globulin therapies administered in the hospital outpatient setting
You may also be interested in...
Plasma Group To Seek Legislation On IVIG Access As CMS Cuts Preadmin Fee
The Alliance for Plasma Therapies will begin working on convincing Congress that legislation is needed to ensure access to intravenous immune globulin therapies now that the preadministration fee in Medicare Part B has been dropped
Plasma Group To Seek Legislation On IVIG Access As CMS Cuts Preadmin Fee
The Alliance for Plasma Therapies will begin working on convincing Congress that legislation is needed to ensure access to intravenous immune globulin therapies now that the preadministration fee in Medicare Part B has been dropped
Increase In Pay For Part B Hospital Outpatient Drugs Needed, Groups Tell CMS
CMS' proposal to drop Medicare Part B drug reimbursement to average sales price plus 4 percent in the hospital outpatient setting is being met with calls for the agency to return to ASP plus 6 percent, the same rate physicians are reimbursed for drugs administered in their offices